Riskpilot← Back to searchSign inGet full accessCodeZero pharmed AB
ABActiveOrg 5590242433Storgatan 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20150 employees
Revenue 2025
SEK 3M
+161% vs 2024
EBITDA margin
-2.8%
-340% vs 2024
Equity ratio
5.2%
Financial strength
Net profit 2025
SEK -95K
-371% vs 2024
| Revenue | SEK 3M | +161% |
| EBITDA | SEK -84K | -340% |
| Net profit | SEK -95K | -371% |
| Total assets | SEK 1,4M | -5% |
| Equity | SEK 71K | +8% |
| Employees | 0 | — |
Legal name
CodeZero pharmed AB
Org number
5590242433
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
26 augusti 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva försäljning och marknadsföring av läkemedel, naturläkemedel och medicintekniska produkter i Norden jämte därmed förenlig verksamhet.
Address
Storgatan 4
Email
hans@theblocnordic.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 24 | 0 | 0 | 0 | 0 | 0 | 1 162 | 3 030 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | 140 | 2 265 | −16 | −35 | −254 | −1 | −20 | 35 | −84 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 140 | 2 265 | −16 | −35 | −254 | −1 | −20 | 35 | −84 |
| Net financials | — | — | −2 | −10 | — | — | — | — | −11 |
| Profit before tax | 105 | 2 300 | −18 | −45 | −254 | −1 | −20 | 35 | −95 |
| Tax | −23 | −508 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 82 | 1 792 | −18 | −45 | −254 | −1 | −20 | 35 | −95 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 458 | 2 527 | 2 460 | 1 900 | 1 646 | 70 | 45 | 1 431 | 1 364 |
| Equity | 132 | 1 924 | 1 906 | 1 860 | 1 606 | 50 | 30 | 66 | 71 |
| Long-term debt | 1 210 | 0 | 0 | 0 | 0 | 0 | 0 | 250 | 500 |
| Short-term debt | 81 | 604 | 554 | 40 | 40 | 20 | 15 | 1 115 | 793 |
| Total debt | 1 291 | 604 | 554 | 40 | 40 | 20 | 15 | 1 365 | 1 293 |
EBITDA margin
-2.8%
This company
15.8%
Market median
-118% vs market
20162025
Equity ratio
5.2%
This company
38.2%
Market median
-86% vs market
20162025
Return on equity
-133.8%
This company
18.4%
Market median
-827% vs market
20162025
Net profit margin
-3.1%
This company
8.1%
Market median
-138% vs market
20162025
Asset turnover
2.22×
This company
1.12×
Market median
+98% vs market
20162025
Debt / equity
18.21×
This company
0.62×
Market median
-2837% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-01-01 – 2024-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-08-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MD | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CodeZero pharmed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Daniel Andersson | Audit | 0 companies |
| Hans Victor Oskar Lindh | Deputy Board Member | 0 companies |
| Hans Erik Vilhelm Lindh | Board of Directors | 0 companies |